Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von GraveDigger 

Hims & Hers Health Inc. diskutieren

Hims & Hers Health Inc.

WKN: A2QMYY / Symbol: HIMS / Name: Hims & Hers Health / Aktie / ? /

16,25 €
-16,56 %

Hims & Hers Health, Inc. (NYSE: HIMS) was upgraded by analysts at Wall Street Zen from a "hold" rating to a "buy" rating.
Ratings data for HIMS provided by MarketBeat

Einschätzung Buy
Rendite (%) -59,22 %
Kursziel 73,86
Veränderung
Endet am 04.11.26

Hims & Hers Health (NYSE:HIMS) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $85.00 price target on the stock.
Ratings data for HIMS provided by MarketBeat

Einschätzung Sell
Rendite (%) -59,22 %
Kursziel 27,80
Veränderung
Endet am 04.11.26

Hims & Hers Health (NYSE:HIMS) had its price target raised by analysts at Bank of America Corporation from $28.00 to $32.00. They now have an "underperform" rating on the stock.
Ratings data for HIMS provided by MarketBeat

Hims & Hers Health (NYSE:HIMS) is now covered by analysts at Barclays PLC. They set an "overweight" rating on the stock.
Ratings data for HIMS provided by MarketBeat

Hims & Hers Health (NYSE:HIMS) had its "sell" rating reaffirmed by analysts at Citigroup Inc..
Ratings data for HIMS provided by MarketBeat

Einschätzung Buy
Rendite (%) -29,03 %
Kursziel 50,53
Veränderung
Endet am 02.02.27

Hims & Hers Health (NYSE:HIMS) had its price target lowered by analysts at BTIG Research from $85.00 to $60.00. They now have a "buy" rating on the stock.
Ratings data for HIMS provided by MarketBeat

Einschätzung Sell
Rendite (%) 8,48 %
Kursziel 17,77
Veränderung
Endet am 09.02.27

Hims & Hers Health (NYSE:HIMS) had its price target lowered by analysts at Bank of America Corporation from $26.00 to $21.00. They now have an "underperform" rating on the stock.
Ratings data for HIMS provided by MarketBeat

Einschätzung Sell
Rendite (%) 9,17 %
Kursziel 13,96
Veränderung
Endet am 09.02.27

Hims & Hers Health (NYSE:HIMS) had its price target lowered by analysts at Citigroup Inc. from $30.00 to $16.50. They now have a "sell" rating on the stock.
Ratings data for HIMS provided by MarketBeat